Previous Article | Next Article 
Applied and Environmental Microbiology, September 1999, p. 3936-3941, Vol. 65, No. 9
0099-2240/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
A Most-Probable-Number Assay for Enumeration of
Infectious Cryptosporidium parvum Oocysts
Theresa R.
Slifko,*
Debra E.
Huffman, and
Joan B.
Rose
Department of Marine Science, University of
South Florida, St. Petersburg, Florida
Received 5 October 1998/Accepted 9 June 1999
 |
ABSTRACT |
Cryptosporidium is globally established as a
contaminant of drinking and recreational waters. A previously described
cell culture infectivity assay capable of detecting infectious oocysts was adapted to quantify viable oocysts through sporozoite invasion and
clustering of foci. Eight experiments were performed by using oocysts
less than 4 months of age to inoculate host HCT-8 cell monolayers.
Oocysts were diluted in a standard 5- or 10-fold multiple dilution
format, levels of infection and clustering were determined, and the
most probable number (MPN) of infectious oocysts in the stock
suspension was calculated. The MPN was compared to the initial oocyst
inoculum to determine the level of correlation. For oocysts less than
30 days of age, the correlation coefficient (r) was 0.9726 (0.9306 to 0.9893; n = 20). A two-tailed P
value (alpha = 0.05) indicated that P was less than
0.0001. This strong correlation suggests that the MPN can be used to
effectively enumerate infectious oocysts in a cell culture system. Age
affected the degree of oocyst infectivity. Oocyst infectivity was
tested by the focus detection method (FDM)-MPN assay and in BALB/c mice
before and after treatment with pulsed white light (PureBrite). The
FDM-MPN assay and animal infectivity assays both demonstrated more than
a 4 log10 inactivation. Municipal water systems and a host
of other water testing organizations could utilize the FDM-MPN assay
for routine survival and disinfection studies.
 |
INTRODUCTION |
Cryptosporidium parvum
was first associated with human illness in the 1970s (5, 6).
The organism's environmentally stable oocysts are transmitted by the
fecal-oral route, often through contaminated drinking water. Outbreaks
have occurred as a result of oocyst resistance to disinfectants
commonly used in drinking water treatment. Within the last 12 years, 19 documented outbreaks in unrelated geographic areas have occurred in the
United States, Canada, United Kingdom, and Japan, affecting more than
an estimated 427,000 individuals (4, 31). Consequently, this
organism has become a major concern to public health and the drinking
water industry.
Cell culture technology has developed into a tool that can be used to
study C. parvum in an environment most similar to the situation in vivo without using animal models (13, 29, 30, 32-34,
36). The research described here uses the previously described focus detection method (FDM) set up in a multiple dilution format (27-29). The autoinfectious nature of the
Cryptosporidium life cycle was observed to begin 12 h
after incubation, and by 48 h, an average ratio of 17.9 foci to
each oocyst was observed (29). Presumably, nonsynchronous
excystation and infection were occurring during this complex life
cycle, and the parasites produced clusters of reproductive stages in
the host monolayer after an extended incubation period. At first, this
confounded the ability to directly count the number of infected foci in
the host cells. Rather than counting the individual foci, a presence or
absence observation was made after 48 h of incubation and was used
to detect one infectious oocyst or fewer (based upon dilution) per well
in vitro.
The most-probable-number (MPN) method of enumerating
microorganisms (specifically, bacteria) was adopted as a method to
quantify the number of infectious oocysts. The method entails making a dilution series, plating in replicate, incubating the samples for an
adequate period, and scoring the presence of growth. In the cell
culture system, cluster presence (and absence) can easily be detected
with the FDM and used to determine the number of viable organisms (in
this case, infectious oocysts) per milliliter in a sample by the MPN
method. Tables made by Halvorson and Ziegler (15) have
traditionally been consulted for the MPNs; however, computer programs
have enabled researchers to obtain a more accurate number and allow
nonstandard volumes and dilutions to be used (11, 21). The
objective of this study was to standardize and test statistically the
reproducibility of the MPN method by using the cell culture FDM for
infectious oocysts.
 |
MATERIALS AND METHODS |
C. parvum oocysts less than 4 months old were
obtained from Pleasant Hill Farm, Iowa. The original strain was
obtained from a naturally infected cow. The oocysts were perpetuated in
newborn calves, purified by an ethyl ether and Percoll-sucrose gradient procedure (according to a protocol that can be obtained from Pleasant Hill Farm), and stored at 4°C in phosphate-buffered saline (PBS) with
antibiotics (penicillin and streptomycin). Upon delivery, each oocyst
lot number was counted with a hemacytometer and concentrations were
recorded. All lot numbers were in concentrations greater than
106 oocysts per ml. Aliquots used for cell culture
infection were processed as described below. Cell culture infectivity
testing was performed simultaneously with in vitro excystation and
vital dye exclusion to compare the viabilities determined by the three assays (3, 25).
Eight oocyst lots (from different calves) were evaluated, with three to
eight replicate experiments/lot, in a total of 34 experiments in order
to determine the variability of lot numbers and the FDM-MPN method.
Each experiment was set up in a multiple dilution format, and 10- or
5-fold dilutions with three to six replicates per dilution were used.
In vitro cell culture.
The cell culture system has
previously been described (27, 28). A brief description
(with changes) is presented here. Human ileocecal adenocarcinoma cells
(HCT-8 cells) were maintained in 75-cm2 tissue culture
flasks and passaged every 2 or 3 days. LabTech II (Nalgene Nunc,
Naperville, Ill.) eight-well chamber slides were seeded with 5 × 105 cells per well and grown to approximately 60 to 80%
confluency in a 5% CO2 atmosphere at 37°C for 24 to
72 h. HCT-8 maintenance medium contained RPMI 1640 supplemented
with 5% fetal bovine serum (Atlanta Biologicals), 2% 1 M HEPES, and
1% 200 mM L-glutamine. No antibiotics were used.
Oocyst preparation.
Once the monolayer was established,
C. parvum oocysts were prepared. Oocysts were pretreated
with 10% (vol/vol) bleach (5.2% sodium hypochlorite) (4°C) and
washed by centrifugation after 5 to 8 min in the bleach solution. Stock
microscopic oocyst counts of the oocyst suspensions were determined by
a direct hemacytometer count, and 10- or 5-fold oocyst dilutions in
growth medium were prepared in sterile polypropylene microcentrifuge
tubes. Each dilution was pipetted onto cell monolayers in three or six
replicate wells. The entire volume of each diluted oocyst suspension
was inoculated. The cultures were incubated in a 5% CO2
atmosphere at 37°C for 48 h (the 90-min washing step previously
described [29] was excluded because no deleterious
effects to the host cells from the toxicity caused by the oocysts
excysting have been noted in the diluted oocyst suspensions). Controls
assayed concurrently for each experiment included uninoculated cell
monolayers in two wells on each slide as negative controls.
Uninoculated wells also served to determine if the chamber slides were
leaking or if any transfer between wells occurred.
Antibody labeling with the FDM.
Well chamber slides were
fixed with 100% methanol and labeled by an indirect antibody procedure
as previously described (29). Rat antisporozoite polyclonal
antibody, generously provided by Steve Upton (Kansas State University,
Manhattan, Kans.) and Waterborne, Inc. (New Orleans, La.), was used as
the primary antibody, while anti-rat fluorescein
isothiocyanate-conjugated antibody (Sigma) was used as the secondary antibody.
Enumeration.
Fixed and labeled slides were examined by
epifluorescence microscopy at a ×200 magnification, and each well was
scored as either positive or negative. Positive infection was
determined by the presence of visible sporozoite invasion that produced
an infection focus, and clustering, a result of secondary infection, was determined when numerous life stages were present. When cells appeared positive for infection, a confirmation of
Cryptosporidium life stages (meronts and microgametes, etc.)
was made at ×400 magnification and/or under oil at a ×1,000
magnification. Both invasion and replication in vitro were required to
score the well as positive. When both invasion and replication were not
present, the well was scored as negative.
The MPN of infectious oocysts was determined by using the information
collection rule (ICR) general purpose Most Probable Number Calculator,
version 1.00 (20). The ICR program was modified from a
previously published version specifically for the application of total
cultivable viruses (MPNv) for samples processed under the ICR
(19). The program enables the user to enter the number of
replicates and dilutions, volumes used, and dilution factors to
generate an MPN with confidence intervals. The program is easy to use
and is preferred to referring to tables. The MPN data were statistically analyzed with the GraphPad Prism software (San Diego, Calif.) and Excel.
Percent infectivity was determined by the following formula: percent
infectivity = (MPN per ml/microscopic oocyst count per
milliliter
of the stock) ×
100.
In vitro viability assays.
Excystation and vital dye
exclusion methods were also used to evaluate viability (3,
25). The inclusion and/or exclusion of the fluorogenic vital dyes
DAPI (4',6-diamidino-2-phenylindole) and propidium iodide (PI) within
oocysts was examined microscopically with an Olympus model BH2
microscope equipped with a UV filter block (350-nm excitation and
450-nm emission) for DAPI and a green filter block (500-nm excitation
and 630-nm emission) for PI. Proportions of ruptured (ghost), PI(+),
DAPI(+)-PI(
), and DAPI(
)-PI(
) oocysts were quantified
(3).
Excystation procedures included the use of excysting fluid (0.5%
trypsin and 1.5% sodium taurocholate in tissue culture with
PBS) to
incubate oocysts for 90 min at 37°C (
25). Sporozoites,
intact oocysts, and oocyst shells were counted under ×400
magnification
by Nomarski differential interference contrast
microscopy. A total
of 300 oocysts were counted per experiment. As an
additional experimental
control, the sporozoite yield viability was
determined by dividing
the sporozoite yield by 4 (the theoretical
number of sporozoites
per oocyst) and multiplying the resulting factor
by
100.
Animal infectivity.
Oocyst infectivity was evaluated by
modified neonatal BALB/c mouse infectivity assay in addition to cell
culture infectivity (1). Inactivation experiments were
performed by using a broad-spectrum pulsed white light water treatment
device (PureBrite, San Diego, Calif.) (35). Pregnant BALB/c
mice were shipped overnight from Jackson Labs (Bar Harbor, Maine) to
Michael Arrowood (Centers for Disease Control and Prevention, Atlanta,
Ga.). Oocyst samples were packed on ice and shipped by overnight
express to Michael Arrowood for inoculation into 4-day-old mice. Groups
of 5 to 10 replicate mice were administered oocyst doses in a dilution
series (106, 105, 104, and
103) by oral gavage and sacrificed 7 days postinoculation
by CO2 inhalation. Mouse intestinal tracts were removed,
and a portion of the terminal ileum from each mouse was placed in 2.5%
potassium dichromate and vigorously vortexed in sterile deionized
water. Oocysts were recovered and isolated by using a discontinuous
sucrose gradient. The rest of the digestive tract from each dosage
group was pooled and was likewise processed in an attempt to detect low
numbers of oocysts that may be missed in individual mice. Each sample
was incubated with a C. parvum oocyst-specific monoclonal antibody (OW50) conjugated with fluorescein isothiocyanate and analyzed
by flow cytometry as previously described (1). The MPN
program was used to estimate the number of viable oocysts.
 |
RESULTS |
Oocyst preparations representing eight different lots ranged from
11 to 94 days of age (Table 1). The
average MPN for all lots was 5.4 × 103 (on a
normalized scale) and ranged from 1.3 × 103 to
1.6 × 104 infectious oocysts per ml. The mean percent
infectivity for all lot numbers and ages tested to date in the cell
culture system ranged from 0.97 to 73.80%, with an average of 20.32%
infectious oocysts (n = 34; standard deviation = ±21.49). Between three and seven replicate experiments were performed
for each lot of oocysts. Several experiments used individually
bleach-treated oocyst preparations for each dilution series, while
others used a single oocyst preparation. Experiments that used the same
bleach preparation for each dilution series exhibited little or no
variability among the MPNs. In many cases, the same MPN was produced.
For example, lot 4 oocysts (18 days of age) were bleach treated, and
three separate sets of dilutions were made from the same bleached
stock. The three experiments showed 1.19 × 104,
1.01 × 104, and 1.01 × 104 MPNs of
infectious oocysts/ml and the proportions of infective oocysts were
47.59, 40.47, and 40.47%, respectively.
Several lots were assayed repeatedly as the oocysts aged (at 4°C in
PBS). The MPNs produced revealed differences among each experiment, and
subtle changes in infectivity were observed. To determine the source of
variability, all experiments were plotted to show the relationship of
each lot number with the percent infectious oocysts and age (Fig.
1). Figure 1A shows the percent infection plotted against age for all lots tested in the cell culture system. Figure 1B shows the regression comparison of the percent infectious oocysts with age for four oocyst lot numbers. Both lot number and age
were factors associated with the variation observed with infectivity.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 1.
Percent infectivity by age of C. parvum
oocysts. (A) All lot numbers tested with the cell culture FDM-MPN assay
(n = 34). (B) Comparison of the linear regression
analysis from four lot numbers. Percent infectivity is determined by
the following formula: [(MPN/milliliter)/(stock oocyst
count/milliliter)] × 100.
|
|
Figure 2 shows the relationship between
the hemacytometer count (number of oocysts/ml) and the MPN/ml for
oocysts less than or greater than 30 days of age. Correlation
coefficients (r) were 0.9726 and 0.9241 for oocysts less
than and greater than 30 days of age, respectively (P < 0.0001). The r value for all experiments (all ages)
combined was 0.4081 (95% confidence interval [CI], 0.0811 to 0.6558 [n = 34]) (P = 0.0166). Stock oocyst counts for oocysts less than 30 days of age were statistically equivalent to the
MPNs calculated; however, the relationship between the oocyst inoculum
and the MPN diverged as the oocysts aged.

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 2.
Linear regression comparison of the number of
oocysts/milliliter inoculated and the MPN/milliliter calculated for
oocysts less than or greater than 30 days of age.
|
|
The log10 of the ratio between the stock oocyst
count/milliliter and the MPN/milliliter were compared with age for each
experiment (Fig. 3). As the oocyst age
increased, the ratio of the inoculum/milliliter to the MPN/milliliter
generally became more negative. Oocysts beyond 30 days of age had a
difference in ratios >
1.0 log10 in 92% (12 in 13) and
>
1.5 log10 in 46% (6 in 13) of the experiments. Oocysts
30 days of age or less had only 19% (3 in 21) of ratios that were
>
1.0 log10 different.

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 3.
Comparison of the log of the ratio of stock oocyst
count/milliliter and MPN/milliliter with age for all experiments.
|
|
Table 2 compares the average percent
infectivity and viability of various oocyst lot numbers. The average
infectivity (by the FDM) and viability (by excystation, sporozoite
yield, and DAPI-PI) varied considerably for each lot number.
Correlation values (r) of the FDM with excystation,
sporozoite yield, and DAPI-PI were 0.1340,
0.2249, and
0.8295,
respectively, which demonstrates a significant difference between
oocyst in vitro infectivity and surrogate viability. Correlation
(r) between excystation and DAPI-PI was 0.0335 for this
study.
Figure 4 presents the comparison between
the infectivity and viability assays for oocysts less than or greater
than 30 days of age (n = 8). A statistical difference
in infectivity by the FDM and viability by excystation was observed for
oocysts less than 30 days of age when compared to that of oocysts
greater than 30 days of age. No statistical difference in viability by
DAPI-PI was observed for oocysts less than or greater than 30 days of age. It has generally been accepted that oocysts less than 90 days of
age and stored in PBS at 4°C are viable as long as they exhibit ample
excystation and vital dye exclusion. This study found that the percent
infectious oocysts (by the FDM) decreased as the oocysts aged after 30 days and infectivity was significantly different from viability by the
surrogate microscopic viability assays.

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 4.
Comparison of in vitro infectivity (by the FDM-MPN
method) and viability (by excystation and DAPI-PI) of oocysts less than
or greater than 30 days of age. Error bars indicate standard
deviations.
|
|
Table 3 shows the comparison between cell
culture and BALB/c mouse infectivity. For the same lot of oocysts, the
result of the FMD-MPN method was slightly higher than the mouse MPN of
infectious oocysts (15 to 9.6 times greater) in untreated water
samples. Cell culture and animal infectivity both showed similar
reductions in the MPN/milliliter for infectious oocysts after treatment
by pulsed white light (broad spectrum) (PureBrite) (16).
After treatment, MPNs were 31.00 and 7.41 compared to <5.64 and
20.17/ml for cell culture and mouse infectivity, respectively. More
than a 4 log10 inactivation was observed.
Charles N. Haas (Drexel, Pa.) performed a preliminary analysis of the
cell culture data (by maximum likelihood) and computed the best-fit
logistic relationship between the oocyst dose per well and the MPN
infectivity response for all experiments (14). The analysis
showed more scatter between data points at a given dose range than
would be expected by chance alone. Based on the results of this study,
the scatter is likely due to age and lot variability. However, despite
the scatter, the 50% infective dose (ID50) in the cell
culture system was shown to be approximately 10 oocysts.
 |
DISCUSSION |
Within the past several years, innovative cell culture technology
has emerged as an alternative to various in vivo and in vitro
infectivity and viability assays. In an effort to assess the
inactivation of high concentrations of C. parvum oocysts, researchers are exploring the applications of infectivity assays with
immunolabeling such as the FDM (27-30) and nucleic
acid-based techniques such as the PCR and in situ hybridization
(24, 26). The analysis presented here demonstrates the use
of an in vitro assay to assess the infectivity of the protozoan
parasite C. parvum, by immunolabeling infected human cells.
By determining the presence or absence of infection in a multiple
dilution series, the MPN of infectious oocysts can be quantified easily
when used in combination with the FDM. The MPN generated by the program
is provided with CIs that allow the user to analyze the differences
between samples and demonstrates an application for use with survival
and disinfection studies. To date, only semiquantitative in vitro
infectivity assays have been used (26).
Antibody staining of infected cells provides an advantage over
molecular detection methods such as PCR and in situ hybridization because the clustering of foci and specific life stages can be seen.
This is a clear indication that reproduction has occurred. Sporozoites
have been observed to excyst, initiate invasion of the host cells, but
then not go further past that stage even after 48 h of incubation
(16, 28). In this study, oocysts after pulsed broad-spectrum
light treatment were observed to excyst and initiate infection
(minimal) and they did form single foci. These oocysts could not
proceed past the sporozoite invasion stage after 48 h of
incubation, and thus, no infection clusters were observed. Molecular
assays may detect the DNA or RNA produced in the invasion stage and may
overestimate the total number of infectious oocysts.
The percent viable and infectious oocysts for each lot number varied
considerably, indicating that there was significant lot-to-lot variability. Several freshly isolated oocyst lot numbers were less than
10% infectious. Oocyst processing to purify the oocysts from feces may
contribute to the variability (e.g., defatting feces during process
using ethyl ether, etc.). Future work will evaluate different oocyst
purification assays to determine the effects on the oocysts.
The infectivity of all oocyst lot numbers decreased as the oocysts
aged. Belosevic et al. showed similar findings using vital dyes for
oocysts isolated from different calves and stored at 4°C
(2). This variation in the viability and infectivity of different oocyst lot numbers and ages suggests that the oocysts are
more affected by aging than previously thought, and each lot number
should be analyzed before use for survival and disinfection studies.
This is the first study to report, quantitatively, oocyst viability
over time by an infectivity assay. Several previous studies on oocyst
infectivity or inactivation did not account for oocyst age prior to
use. This study suggests that 30 days may be the maximum storage time,
prior to experimentation, for maintaining a high proportion of
infectious oocysts and that age may be an important quality control issue.
In our laboratory, the FDM-MPN method has now been used in disinfection
studies for the water and food industry to determine oocyst
inactivation after exposure to various water activities, pulsed white
light, UV light, chlorine dioxide, ozonation and ultrahigh pressure. By
using the MPNs, log10 and percent reductions can be
calculated (16, 28, 30). The assay has been used for
environmental (secondary sewage effluent [27]) and
turbid water samples, which can be a problem in other viability assays such as microscopy, PCR, and in situ hybridization due to inhibition by
the particulates. Future work will test the limits of particulates in
the cell culture system.
Infectious oocysts can be detected repeatedly at very low
concentrations (as low as 1 oocyst per ml determined by the FDM), indicating the high-level sensitivity of this assay. For each experiment, the oocysts were diluted to less than 1 oocyst per ml.
Clusters of foci were detected at these highly diluted subsamples and
were obvious against the dark host monolayer. The polyclonal antibody
labels all the life stages present, thus enabling detection at low
concentrations. Several monoclonal antibodies were tested; however,
these did not have the same specificity or ability to pick up all the
life stages as the polyclonal ones (data not presented). Since the
FDM-MPN assay is both cell culture and antibody based, it may be very
specific to infection only by C. parvum; however, the
experiments to test specificity with all isolates and
Cryptosporidium species have not been performed.
Cryptosporidium muris was tested, and life stages past the
initial trophozoite stage and clustering were not detected. Future
efforts will focus on natural isolates from humans and animals,
including various genotypes (24).
Vital dye and excystation methods have been routinely used for survival
and disinfection experiments (9, 17, 18, 25). Frequently,
researchers use animal models to validate the surrogate in vitro
results (12, 23). Oftentimes, however, only the surrogate assays are used. Campbell et al. demonstrated the usefulness of the
DAPI-PI and excystation methods used in their study for small numbers
of oocysts and showed a good correlation between excystation and
DAPI-PI (r2 = 0.997) (3). We
have recently reported a comparison of results with DAPI-PI,
excystation, and FDM-MPN with animal infectivity (30). In
this study and previous work, the FDM-MPN method consistently determined a lower-level viability than either vital dye staining or
excystation, suggesting that these surrogates overestimate the actual
oocyst infectivity, particularly for oocysts >30 days of age. The
FDM-MPN method appears to be similar to animal infectivity and further
comparisons are ongoing. The maximum likelihood of the cell culture
data showed an ID50 of around 10 oocysts, well below any
other reported ID50 in animal models, suggesting that the
cell culture system is a conservative assay. Previously reported ID50s of C. parvum in mice were 79, 83, and 100 oocysts (8, 10, 22) and in humans were 132 oocysts
(7). A high degree of scatter in the maximum likelihood
analysis of the cell culture data was shown. The factors contributing
to this are unknown; however, the variability of oocysts from different
lot numbers may be a contributing factor.
In conclusion, the FDM-MPN method has been shown to be an excellent and
reproducible assay for quantifying oocyst infectivity in vitro. Oocyst
age is an important issue that must be addressed before proceeding with
disinfection projects. It is also notable that the cell culture assay
is more sensitive than surrogate in vitro viability assays. When the
FDM-MPN method was compared to animal models, a similar level of
infectivity was determined, suggesting that the FDM can be used as an
alternative to animal assays.
 |
ACKNOWLEDGMENTS |
The research described in this article has been funded in part by
the U.S. Environmental Protection Agency under assistance agreement
CR.-8241580 to the University of South Florida.
We thank Steve Upton and Keith Woods, Kansas State University, for
providing primary antiserum. We also thank Charles N. Haas, Drexel
University, for analyzing the data. We are grateful for constructive
criticism and guidance from Walter Jakubowski, WaltJay Consulting. We
are also indebted to Michael Arrowood for animal infectivity analysis.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Marine Science, University of South Florida, 140 7th Ave. S, St.
Petersburg, FL 33701-5016. Phone: (727) 553-3930. Fax: (727) 553-1189. E-mail: slifko{at}seas.marine.usf.edu.
 |
REFERENCES |
| 1.
|
Arrowood, M. J.,
M. R. Hurd, and J. R. Mead.
1995.
A new method for evaluating experimental cryptosporidial parasite loads using immunofluorescent flow cytometry.
J. Parasitol.
81:404-409[Medline].
|
| 2.
|
Belosevic, M.,
R. A. Guy,
R. Taghi-Kilani,
N. F. Neumann,
L. L. Gyurek,
L. R. J. Liyange,
P. J. Millards, and G. R. Finch.
1997.
Nucleic acid stains as indicators of Cryptosporidium parvum oocyst viability.
Int. J. Parasitol.
27:787-798[Medline].
|
| 3.
|
Campbell, A. T.,
L. J. Robertson, and H. V. Smith.
1992.
Viability of Cryptosporidium parvum oocysts: correlation of in vitro excystation with inclusion or exclusion of fluorogenic vital dyes.
Appl. Environ. Microbiol.
58:3488-3493[Abstract/Free Full Text].
|
| 4.
|
Craun, G. F., et al.
1998.
Waterborne outbreaks of cryptosporidiosis.
J. Am. Water Works Assoc.
90:81-91.
|
| 5.
|
Crawford, F. G., and S. H. Vermund.
1988.
Human cryptosporidiosis.
Crit. Rev. Microbiol.
16:113-159[Medline].
|
| 6.
|
Dupey, J. P.,
C. A. Speer, and R. Fayer.
1990.
Cryptosporidiosis of man and animals.
CRC Press, Boca Raton, Fla.
|
| 7.
|
Dupont, H. L.,
C. L. Chappeli,
C. R. Sterling,
P. C. Okhuysen,
J. B. Rose, and W. J. Jakubowski.
1995.
The infectivity of Cryptosporidium parvum in healthy volunteers.
N. Engl. J. Med.
332:855-859[Abstract/Free Full Text].
|
| 8.
|
Ernest, J. A.,
B. L. Blagburn, and D. S. Lindsay.
1986.
Infection dynamics of Cryptosporidium parvum (Apicomplexa: Cryptosporiidae) in neonatal mice (Mus musculus).
J. Parasitol.
75:796-798.
|
| 9.
|
Fayer, R., and T. Nerad.
1996.
Effects of low temperatures on viability of Cryptosporidium parvum oocysts.
Appl. Environ. Microbiol.
62:1431-1433[Abstract].
|
| 10.
|
Finch, G. R.,
C. W. Daniels,
E. K. Black,
F. W. Schaefer III, and M. Belosevic.
1993.
Dose response of Cryptosporidium parvum in outbred neonatal CD-1 mice.
Appl. Environ. Microbiol.
59:3661-3665[Abstract/Free Full Text].
|
| 11.
|
Gonzalez, J. M.
1996.
A general purpose program for obtaining most probable number tables.
J. Microbiol. Methods
26:215-218.
|
| 12.
|
Graczyk, T. K.,
R. Fayer,
M. R. Cranfield, and R. Owens.
1997.
Cryptosporidium parvum oocysts recovered from water by the membrane filter dissolution method retain their infectivity.
J. Parasitol.
83:111-114[Medline].
|
| 13.
|
Griffiths, J. K.,
R. Moore,
S. Dooley,
G. T. Keusch, and S. Tzipori.
1994.
Cryptosporidium parvum infection of Caco-2 cell monolayers induces an apical monolayer defect, selectively increases transmonolayer permeability, and causes epithelial cell death.
Infect. Immun.
62:4506-4514[Abstract/Free Full Text].
|
| 14.
|
Haas, C. N.
1989.
Estimation of microbial densities from dilution count experiments.
Appl. Environ. Microbiol.
55:1934-1942[Abstract/Free Full Text].
|
| 15.
|
Halvorson, H. O., and N. R. Ziegler.
1933.
Application of statistics to problems in bacteriology. I. A means of determining bacterial population by the dilution method.
J. Bacteriol.
25:101-121[Free Full Text].
|
| 16.
| Huffman, D. E., T. R. Slifko, M. J. Arrowood, and J. B. Rose. Inactivation of bacteria, virus and
Cryptosporidium by a point-of-use device pulsed broad
spectrum white light. Water Res., in press.
|
| 17.
|
Jenkins, M. B.,
D. D. Bowman, and W. C. Ghiorse.
1998.
Inactivation of Cryptosporidium parvum oocysts by ammonia.
Appl. Environ. Microbiol.
64:784-788[Abstract/Free Full Text].
|
| 18.
|
Johnson, D. C.,
C. E. Enriquez,
I. L. Pepper,
T. L. Davis,
C. P. Gerba, and J. B. Rose.
1997.
Survival of Giardia, Cryptosporidium, poliovirus, and Salmonella in marine waters.
Water Sci. Technol.
35:261-268.
|
| 19.
|
Klee, A. J.
1993.
A computer program for the determination of the most probable number and its confidence limits.
J. Microbiol. Methods
18:91-98.
|
| 20.
|
Klee, A. J.
26 January, 1999, revision date.
ICR most probable number calculator, version 1.00. [Online.]
Risk reduction laboratory, U.S. Environmental Protection Agency, Cincinnati, Ohio. http://www.epa.gov/nerc/www/other.htm. 26 July 1999, last date accessed
|
| 21.
|
Koch, A. L.
1982.
Estimation of the most probable number with a programmable pocket calculator.
Appl. Environ. Microbiol.
43:488-490[Abstract/Free Full Text].
|
| 22.
|
Korich, D. G.,
M. M. Marshall,
H. V. Smith,
J. L. Clancy, and C. R. Fricker.
1998.
Cryptosporidium oocyst infectivity: an interlaboratory comparison of the neonatal mouse model, abstr. Q-233, p. 459.
In
Abstracts of the 98th General Meeting of the American Society for Microbiology. American Society for Microbiology, Washington, D.C.
|
| 23.
|
Korich, D. G.,
J. R. Mead,
M. S. Madore,
N. A. Sinclair, and C. R. Sterling.
1990.
Effects of ozone, chlorine dioxide, chlorine, and monochloramine on Cryptosporidium parvum oocyst viability.
Appl. Environ. Microbiol.
56:1423-1428[Abstract/Free Full Text].
|
| 24.
|
Morgan, U. M., and R. C. A. Thompson.
1998.
PCR detection of Cryptosporidium: the way forward?
Parasitol. Today.
14:241-245.
|
| 25.
|
Robertson, L. J.,
A. T. Campbell, and H. V. Smith.
1992.
Survival of Cryptosporidium parvum oocysts under various environmental pressures.
Appl. Environ. Microbiol.
58:3494-3500[Abstract/Free Full Text].
|
| 26.
|
Rochelle, P. A.,
D. M. Ferguson,
T. J. Handojo,
R. DeLeon,
M. H. Stewart, and R. L. Wolfe.
1998.
Development of an infectivity assay for waterborne Cryptosporidium. In Proceedings of the American Water Works Associaton Water Quality Technology Conference.
American Water Works Association, Denver, Colo.
|
| 27.
|
Slifko, T. R.,
D. E. Friedman,
J. B. Rose,
S. J. Upton, and W. Jakubowski.
1996.
Unique cultural methods used to detect viable Cryptosporidium parvum oocysts in environmental samples.
Water Sci. Technol.
35:363-368.
|
| 28.
| Slifko, T. R., D. E. Friedman, J. B. Rose, J. H. Fraser, and K. M. J. Swanson. 1999. Unpublished data.
|
| 29.
|
Slifko, T. R.,
D. Friedman,
J. B. Rose, and W. Jakubowski.
1997.
An in vitro method for detecting infectious Cryptosporidium oocysts with cell culture.
Appl. Environ. Microbiol.
63:3669-3675[Abstract].
|
| 30.
|
Slifko, T. R.,
D. E. Friedman, and J. B. Rose.
1998.
Comparison of 4 Cryptosporidium parvum viability assays: DAPI/PI, excystation, cell culture, and animal infectivity.
In
Proceedings of the American Water Works Association Water Quality Technology Conference. American Water Works Association, Denver, Colo.
|
| 31.
|
Smith, H. V., and J. B. Rose.
1998.
Waterborne cryptosporidiosis: current status.
Parasitol. Today
14:14-22.
|
| 32.
|
Upton, S. J., et al.
1994.
A simple and reliable method of producing in vitro infections of Cryptosporidium parvum (Apicomplexa).
FEMS Microbiol. Lett.
118:45-50[Medline].
|
| 33.
|
Upton, S. J.,
M. Tilley, and D. B. Brillhart.
1994.
Comparative development of Cryptosporidium parvum (Apicomplexa) in 11 continuous host cell lines.
FEMS Microbiol. Lett.
118:233-236[Medline].
|
| 34.
|
Upton, S. J.,
M. Tilley, and D. B. Brillhart.
1994.
Comparative development of Cryptosporidium parvum in MDBK and HCT-8 cells under select atmospheres.
Biomed. Lett.
49:265-271.
|
| 35.
|
U.S. Environmental Protection Agency.
1986.
Pesticide program guide standard and protocol for microbiological water purifiers.
Fed. Regist.
51:19403.
|
| 36.
|
Yang, S.,
M. C. Healey,
C. Du, and J. Zhang.
1996.
Complete development of Cryptosporidium parvum in bovine fallopian tube epithelial cells.
Infect. Immun.
64:349-354[Abstract].
|
Applied and Environmental Microbiology, September 1999, p. 3936-3941, Vol. 65, No. 9
0099-2240/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Helmi, K., Skraber, S., Gantzer, C., Willame, R., Hoffmann, L., Cauchie, H.-M.
(2008). Interactions of Cryptosporidium parvum, Giardia lamblia, Vaccinal Poliovirus Type 1, and Bacteriophages {phi}X174 and MS2 with a Drinking Water Biofilm and a Wastewater Biofilm. Appl. Environ. Microbiol.
74: 2079-2088
[Abstract]
[Full Text]
-
Sifuentes, L. Y., Di Giovanni, G. D.
(2007). Aged HCT-8 Cell Monolayers Support Cryptosporidium parvum Infection. Appl. Environ. Microbiol.
73: 7548-7551
[Abstract]
[Full Text]
-
Connelly, S. J., Wolyniak, E. A., Dieter, K. L., Williamson, C. E., Jellison, K. L.
(2007). Impact of Zooplankton Grazing on the Excystation, Viability, and Infectivity of the Protozoan Pathogens Cryptosporidium parvum and Giardia lamblia. Appl. Environ. Microbiol.
73: 7277-7282
[Abstract]
[Full Text]
-
Ives, R. L., Kamarainen, A. M., John, D. E., Rose, J. B.
(2007). Use of Cell Culture To Assess Cryptosporidium parvum Survival Rates in Natural Groundwaters and Surface Waters. Appl. Environ. Microbiol.
73: 5968-5970
[Abstract]
[Full Text]
-
Schets, F. M., Engels, G. B., During, M., de Roda Husman, A. M.
(2005). Detection of Infectious Cryptosporidium Oocysts by Cell Culture Immunofluorescence Assay: Applicability to Environmental Samples. Appl. Environ. Microbiol.
71: 6793-6798
[Abstract]
[Full Text]
-
Harwood, V. J., Levine, A. D., Scott, T. M., Chivukula, V., Lukasik, J., Farrah, S. R., Rose, J. B.
(2005). Validity of the Indicator Organism Paradigm for Pathogen Reduction in Reclaimed Water and Public Health Protection. Appl. Environ. Microbiol.
71: 3163-3170
[Abstract]
[Full Text]
-
Di Giovanni, G. D., LeChevallier, M. W.
(2005). Quantitative-PCR Assessment of Cryptosporidium parvum Cell Culture Infection. Appl. Environ. Microbiol.
71: 1495-1500
[Abstract]
[Full Text]
-
Quintero-Betancourt, W., Gennaccaro, A. L., Scott, T. M., Rose, J. B.
(2003). Assessment of Methods for Detection of Infectious Cryptosporidium Oocysts and Giardia Cysts in Reclaimed Effluents. Appl. Environ. Microbiol.
69: 5380-5388
[Abstract]
[Full Text]
-
Gennaccaro, A. L., McLaughlin, M. R., Quintero-Betancourt, W., Huffman, D. E., Rose, J. B.
(2003). Infectious Cryptosporidium parvum Oocysts in Final Reclaimed Effluent. Appl. Environ. Microbiol.
69: 4983-4984
[Abstract]
[Full Text]
-
LeChevallier, M. W., Di Giovanni, G. D., Clancy, J. L., Bukhari, Z., Bukhari, S., Rosen, J. S., Sobrinho, J., Frey, M. M.
(2003). Comparison of Method 1623 and Cell Culture-PCR for Detection of Cryptosporidium spp. in Source Waters. Appl. Environ. Microbiol.
69: 971-979
[Abstract]
[Full Text]
-
Rochelle, P. A., Marshall, M. M., Mead, J. R., Johnson, A. M., Korich, D. G., Rosen, J. S., De Leon, R.
(2002). Comparison of In Vitro Cell Culture and a Mouse Assay for Measuring Infectivity of Cryptosporidium parvum. Appl. Environ. Microbiol.
68: 3809-3817
[Abstract]
[Full Text]
-
Arrowood, M. J.
(2002). In Vitro Cultivation of Cryptosporidium Species. Clin. Microbiol. Rev.
15: 390-400
[Abstract]
[Full Text]
-
Weir, S. C., Pokorny, N. J., Carreno, R. A., Trevors, J. T., Lee, H.
(2002). Efficacy of Common Laboratory Disinfectants on the Infectivity of Cryptosporidium parvum Oocysts in Cell Culture. Appl. Environ. Microbiol.
68: 2576-2579
[Abstract]
[Full Text]
-
Oguma, K., Katayama, H., Mitani, H., Morita, S., Hirata, T., Ohgaki, S.
(2001). Determination of Pyrimidine Dimers in Escherichia coli and Cryptosporidium parvum during UV Light Inactivation, Photoreactivation, and Dark Repair. Appl. Environ. Microbiol.
67: 4630-4637
[Abstract]
[Full Text]
-
Chauret, C. P., Radziminski, C. Z., Lepuil, M., Creason, R., Andrews, R. C.
(2001). Chlorine Dioxide Inactivation of Cryptosporidium parvum Oocysts and Bacterial Spore Indicators. Appl. Environ. Microbiol.
67: 2993-3001
[Abstract]
[Full Text]
-
Carreno, R. A., Pokorny, N. J., Weir, S. C., Lee, H., Trevors, J. T.
(2001). Decrease in Cryptosporidium parvum Oocyst Infectivity In Vitro by Using the Membrane Filter Dissolution Method for Recovering Oocysts from Water Samples. Appl. Environ. Microbiol.
67: 3309-3313
[Abstract]
[Full Text]
-
Bukhari, Z., Marshall, M. M., Korich, D. G., Fricker, C. R., Smith, H. V., Rosen, J., Clancy, J. L.
(2000). Comparison of Cryptosporidium parvum Viability and Infectivity Assays following Ozone Treatment of Oocysts. Appl. Environ. Microbiol.
66: 2972-2980
[Abstract]
[Full Text]